The small molecule SC43, a derivative of the kinase inhibitor sorafenib, has been described to activate Shp1 in hepatocellular carcinoma cells, leading to dephosphorylation of downstream signaling proteins, including STAT3 (41, 42). The gene discussed is STAT3; the disease is hepatocellular carcinoma.